![]() |
Evaluating Efficacy of Bortezomib and Carfilzomib in Tr...
February 1, 2023 - Clinical , Featured By: Brian Chung, PharmD Candidate c/o 2024, Peter Chung, PharmD Candidate c/o 2024, and Kevin Kim, PharmD Candidate c/o 2024 Multiple myeloma is a blood cancer that affects an individual’s plasma cells. Plasma cells are white blood cells located in the bone marrow that are responsible for producing antibodies, also known as immunoglobulins.1 Immunoglobulins… |
![]() |
Assessing the Efficacy of Cholecalciferol Versus Ergoca...
February 1, 2023 - Clinical , Featured By: Nancy Yousry, PharmD Candidate c/o 2024 Vitamin D is a multifaceted nutrient needed to maintain homeostasis and proper health. In addition to its role in building and maintaining healthy bones, vitamin D also regulates many important cellular functions in the body, serving as an anti-inflammatory, antioxidative, and neuroprotective agent.1 In general, the two… |
![]() |
Different Dietary Fats and their Association with Cardi...
August 1, 2022 - Clinical , Featured By: Justin Budz, PharmD Candidate c/o 2023 In the United States (US), heart disease is the leading cause of death for both men and women of most racial and ethnic groups, followed by cancer and coronavirus disease 2019 (COVID-19).1 About 659,000 people in the US die from heart disease each year, which encompasses about 1 in… |
![]() |
Balancing Early and Appropriate Antibiotic Therapy and ...
August 1, 2022 - Clinical By: Angela Basir, PharmD Candidate c/o 2023 and Muatasem Jaser, PharmD Candidate c/o 2023 Sepsis is a clinical syndrome defined as a life-threatening organ dysfunction caused by a dysregulated host response to an infection.1 Septic shock is a subset of sepsis in which underlying circulatory and cellular/metabolic abnormalities are profound enough to substantially increase… |
![]() |
The Controversial use of Aducanumab (Aduhelm) for Alzhe...
February 1, 2022 - Clinical , Featured By: Aamir S. Dave, PharmD Candidate c/o 2023 Judith L. Beizer, PharmD, BCGP, FASCP, AGSF Alzheimer’s and Dementia Dementia is characterized by the loss of memory and other cognitive abilities that interfere with daily life. Alzheimer’s is a progressive neurological disease and is the most common type of dementia, accounting for greater than 60-80%… |
![]() |
Molnupiravir: A Prospective Oral Antiviral for Treatmen...
February 1, 2022 - Clinical , Featured By: Justin Budz, PharmD Candidate c/o 2023 On January 19th, 2020, a 35-year-old man in an urgent care clinic in Snohomish County, Washington was the first to be confirmed by the Centers for Disease Control and Prevention (CDC) to be infected with Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2… |
![]() |
Combating Chronic Diseases with a Plant-Based Diet...
December 1, 2021 - Clinical , Featured By: Ashely Dao, PharmD Candidate c/o 2024 In early 2021, about 6 in 10 American adults had a chronic disease. Chronic diseases are the leading cause of death and disability in the United States with 1 in 3 deaths caused by cardiovascular diseases (CVD).¹ The Coronavirus disease 2019 (COVID-19) pandemic has emphasized the impact… |
![]() |
An Overview of Ketamine Cystitis...
December 1, 2021 - Clinical , Featured By: Pallak Sharma, PharmD Candidate c/o 2022 and Mia Cord-Cruz, PharmD Candidate c/o 2022 Ketamine (Ketalar®) is currently approved by the Food and Drug Administration (FDA) for use as a general anesthetic, with additional indications listed within its package insert.1 Ketamine is a highly abused “street drug”, especially in China. To demonstrate, in Hong… |
![]() |
Understanding the MELD and PELD Score and Its Role In L...
October 1, 2021 - Clinical , Featured By: Jason Ifeanyi, PharmD Candidate c/o 2022 The liver is one of the most commonly transplanted solid organs in the United States (US) today. The United Network for Organ Sharing (UNOS) is a mission-driven non-profit that leads the network of transplant hospitals, organ procurement organizations, and thousands of volunteers who are dedicated to saving… |
![]() |
Antiepileptics in Migraine Prophylaxis...
August 1, 2021 - Clinical By: Krishna Tamakuwala, PharmD candidate c/o 2023 Migraines are characterized by episodes of head pain that are often throbbing and frequently unilateral. Migraines are divided into two categories: migraines without aura, known as common migraine, and migraines with aura, known as classical migraine. Migraines without aura are oftentimes associated with typical symptoms like nausea,… |
![]() |
Dravet’s Syndrome and a Novel Antiepileptic Drug: Can...
August 1, 2021 - Clinical , Featured By: Jason Ifeanyi, PharmD Candidate c/o 2022 Epilepsy is a highly prevalent neurological disorder caused by unusual nerve cell activity, and is among one of the most common disease states encountered today in clinical practice. Each year around 150,000 Americans are diagnosed with epilepsy.1 Epilepsy is defined by the World Health Organization (WHO) as… |
![]() |
Emerging Frontiers in Multiple Myeloma Pharmacotherapy...
June 1, 2021 - Clinical , Featured By: Nishanth Viswanath, PharmD Candidate c/o 2022 Multiple myeloma (MM) is a hematological malignancy characterized by an accumulation and proliferation of monoclonal plasma cells in the bone marrow. 1 Throughout the course of the disease, malignant plasma cells induce an overproduction of non-functional immunoglobulin (paraproteins), which is evident during urine and blood screenings. 2… |
![]() |
The Cardiovascular Effects of Cannabis vs. Tobacco Cons...
April 1, 2021 - Clinical , Featured By: Jeng Lee, PharmD Candidate c/o 2022 Throughout the past decade, there has been an increase in the prevalence of medical and recreational consumption of cannabis, also referred to as marijuana. 1 These numbers are expected to rise over the upcoming years in the United States as marijuana use is currently legalized in 33… |
![]() |
New Drug Update: Lemborexant (Dayvigo ®)...
April 1, 2021 - Clinical , Featured By: Cindy Van, PharmD Candidate c/o 2022, Shireen Farzadeh, PharmD, BCPS Insomnia is a condition characterized by difficulty falling asleep, staying asleep, or both, despite an adequate opportunity to sleep. Consequently, insomnia can lead to daytime fatigue, difficulty concentrating, and irritability. This condition can be categorized into short-term and chronic insomnia. While short-term insomnia… |
![]() |
Rybelsus: Novel Oral GLP-1 Agonist and the Future of Or...
April 1, 2021 - Clinical , Featured By: Tanay Maddula PharmD Candidate c/o 2022 Rybelsus (oral semaglutide) was recently approved by the Food and Drug Administration (FDA) in September 2019 to help control blood sugar in adult patients with Type 2 Diabetes alongside diet and exercise. It is the first oral GLP-1 (glucagon like peptide-1) agonist as typical drugs of this… |
![]() |
Emerging Type 3 Diabetes...
April 1, 2021 - Clinical , Featured By: Zarnab Jillani PharmD Candidate c/o 2022 The link between diabetes and Alzheimer’s disease (AD) is a new and ongoing debate given the etiology of AD is still not fully understood. Diabetes continues to be a major public health crisis as diagnoses around the world continue to rise. Diabetes is a chronic disease that… |
![]() |
Increasing Evidence of the Benefits of Statins...
April 1, 2021 - Clinical , Featured By: Pallak Sharma, PharmD Candidate c/o 2022 and Rebecca Samuel, PharmD Candidate c/o 2022 Statins, some of the most well-known cholesterol lowering medications, have been demonstrating increasing evidence of safety and benefits to the elderly patient population. 5 Statins are a class of medication that can help lower the level of low-density lipoprotein (LDL)… |
![]() |
Use of dexamethasone for the treatment of COVID-19: an ...
February 1, 2021 - Clinical , Featured By: Bisma T. Sekhery PharmD. Candidate c/o 2025 COVID-19 has had a significant impact on the health, economic, and social aspects of life for every person. Currently, there is only one Food and Drug Administration (FDA)-approved treatment for COVID-19–remdesivir (Veklury®). The lack of approved therapies makes COVID-19 difficult to treat and increases overall mortality… |
![]() |
Asthma, Alveoli, and Albuterol: A General Overview of A...
December 1, 2020 - Clinical , Featured By: Jeremy Mesias, PharmD Candidate c/o 2022 It starts with a simple cough or a wheeze. Suddenly, it escalates to tightness in the chest. Breathing gets quicker but shallower, making you feel short of breath. These are the most common and recognizable symptoms of an asthma attack. Around the world, nearly 300 million people… |
![]() |
Vancomycin Monitoring for Serious MRSA Infections in Ad...
December 1, 2020 - Clinical , Featured By: Darien Lee, Pharm D Candidate c/o 2021 Vancomycin, a glycopeptide antibiotic, is one of the most commonly used medications in hospitals. Its widespread use is attributed to its efficacy for the treatment and prevention of bacterial infections caused by gram-positive bacteria. One of its most notable features is its coverage of methicillin-resistant Staphylococcus… |
![]() |
Novel agents in the treatment of chronic lymphocytic le...
August 1, 2020 - Clinical , Featured By: Nishanth Viswanath, PharmD Candidate c/o 2022 Introduction Chronic lymphocytic leukemia (CLL) is a hematological malignancy of mature CD5 positive B-lymphocytes that primarily affects elderly patients.1 With the average age of diagnosis being 71, the incidence of CLL is relatively rare in younger populations, though cases have occurred in those under the age of 50.1… |
![]() |
A Closer Glance at Mycobacterium Avium Complex (MAC) In...
August 1, 2020 - Clinical , Featured By: Dana Weinstein, PharmD Candidate c/o 2022 Mycobacterium avium complex (MAC) infection in humans is caused by two main species, Mycobacterium avium and Mycobacterium intracellulare. These species are difficult to differentiate and therefore are collectively referred to as Mycobacterium avium-intracellulare (MAI).1 These acid-fast, atypical nontuberculosis mycobacterium (NTM) are the most common cause of lung disease in the U.S.2 MAC is… |
![]() |
Overview of the use of neuromuscular blocking agents in...
February 1, 2020 - Clinical , Featured By: Joseph DiPaola (PharmD Candidate c/o 2022), Nishanth Viswanath (PharmD Candidate c/o 2022) Neuromuscular blocking agents (NMBAs) are drugs that induce a physiological state of paralysis, and are used in a variety of surgical procedures, disease states, and situations in clinical pharmacy and anesthesiology. Practitioners have been successfully using NMBAs since 1995 after the… |
![]() |
Basal-bolus vs. sliding-scale insulin in hospitalized p...
December 1, 2019 - Clinical , Featured By: Maria Sedky Saad (PharmD Candidate c/o 2021), Shivani Shah (PharmD Candidate c/o 2021) Hyperglycemia is a common condition in hospitalized patients whose glucose levels are normally controlled with oral antidiabetic medications, which are often discontinued upon admission. To circumvent hyperglycemic complications in hospitalized patients with type 1 and type 2 diabetes, glucose levels… |
![]() |
Treatment of iron deficiency anemia...
December 1, 2019 - Clinical , Featured By: Maryam Sekhery, PharmD Candidate c/o 2020 According to the World Health Organization, anemia is defined as having a level of Hemoglobin (Hb) below 13.0 g/dL in male adults, below 12.0 g/dL in female adults who are not pregnant, and below 11.0 g/dL in pregnant women.1 Hemoglobin is an iron-containing oxygen-transport metalloprotein in red… |
![]() |
Potential complications posed by hypocalcemia in wound ...
April 1, 2019 - Clinical , Featured By: Sarah, Hewady, PharmD Candidate c/o 2020 Calcium’s fundamental importance in the early hemostasis phase of wound healing has been established through its role as a cofactor in the blood-clotting cascade, facilitator of platelet aggregation with von Willebrand factor, and activator of protein kinase C, ultimately leading to glycoprotein IIb/IIIa’s increased binding affinity for… |
![]() |
Treatment of initial and recurrent Clostridium difficil...
February 1, 2019 - Clinical , Featured By: Joseph Eskandrous, PharmD Candidate c/o 2019 Clostridium difficile (C. difficile) is a gram-positive, anaerobic, sporogenic bacterium that is primarily responsible for antibiotic-associated diarrhea and is a significant nosocomial pathogen.1 Clostridium difficile infection (CDI) is triggered by toxin production from the bacteria. Normal bacterial flora is disrupted when the colon is colonized with C. difficile… |
![]() |
Targeting biomarkers in immuno-oncology: current agents...
December 1, 2018 - Clinical , Featured By: Jonathan Mercado (PharmD Candidate c/o 2019), Rebecca Sin (PharmD Candidate c/o 2019) Immuno-oncology is an advanced and rapidly growing area of research focused on utilizing the body’s immune system to help fight cancer. Immunotherapy has demonstrated clinical efficacy and unprecedented rates of response in treating specific cancers, usurping the classical approach to chemotherapy and… |
![]() |
Presentation and management of nivolumab (Opdivo®)-ind...
June 1, 2018 - Clinical , Featured By: Shireen Farzadeh, PharmD Candidate c/o 2019 – Nivolumab (Opdivo®) is a monoclonal antibody that blocks programmed death receptor-1 (PD-1). PD-1 plays an important role in the immune checkpoint cascade. It is indicated for the treatment of melanoma, renal cell carcinoma, non-small cell and small cell lung cancer, squamous cell carcinoma of the head and… |
![]() |
Understanding treatment options for chronic pain manage...
April 1, 2018 - Clinical , Featured By: Alex Chu & Joseph Eskandrous (PharmD Candidates c/o 2019) – The geriatric population grows older with each passing day and is more likely to experience chronic pain due to shifts in body composition and pathological diseases.1 Chronic geriatric pain may be defined as an unpleasant sensory and emotional experience associated with actual or potential… |
![]() |
Assessing the current treatment recommendations for Gra...
February 1, 2018 - Clinical , Featured By: Natalie Rodriguez, PharmD Candidate 2019 Philadelphia College of Pharmacy, University of the Sciences and Stacey Gorski, Assistant Professor of Biological Sciences – PRESS SUMMARY The most common cause of hyperthyroidism, or an over-active thyroid, is an autoimmune disease known as Graves’ disease. In patients with Graves’ disease, the immune system attacks the thyroid gland… |
![]() |
Acetaminophen toxicity and n-acetylcysteine...
February 1, 2018 - Clinical , Featured By: Kathleen Horan, PharmD Candidate c/o 2020 – During my institutional Introductory Pharmacy Practice Experiential (IPPE) rotation in the emergency department at NYU Winthrop University Hospital in the spring of 2018, I witnessed a variety of interesting cases while shadowing my preceptor, emergency department pharmacist Megan Czuba, PharmD. Among these emergencies cases, I witnessed a… |
![]() |
Review on the use of hydroxyurea – 50 years of FD...
December 1, 2017 - Clinical , Featured By: Jonathan Mercado, PharmD Candidate c/o 2019 – Hydroxyurea is a versatile, multi-functional drug that has been used for decades in the United States. It was originally approved in 1967 as an antineoplastic drug for use in multiple cancers including melanoma, ovarian cancer, and most prominently chronic myeloid leukemia (CML).1 Although approved as a chemotherapeutic… |
![]() |
Safety and efficacy of a new drug: sofosbuvir/velpatasv...
October 1, 2017 - Clinical , Featured By: Shireen Farzadeh, PharmD Candidate c/o 2019 – Sofosbuvir/velpatasvir/voxilaprevir (Vosevi®) is the first pangenotypic fixed-dose combination tablet that includes 400 mg of sofosbuvir, a Hepatitis C virus (HCV) nucleotide analog, 100 mg of velpatasvir, an HCV NS5A inhibitor, and 100 mg of voxilaprevir, an HCV NS3/4A protease inhibitors.1,2 In the interest of brevity, sofosbuvir/velpatasvir/voxilaprevir will… |
![]() |
Pharmacy Pearls: Current Treatment for Hepatitis C...
June 1, 2017 - Clinical , Featured By: Vicky Liu, PharmD Candidate c/o 2018 – Hepatitis is an inflammation of the liver commonly caused by viruses which can lead to self-limitation, fibrosis, cirrhosis, or liver cancer. Viral hepatitis is categorized into five types: A, B, C, D, and E. Of the five types, A, B, and C are the most prevalent in… |
![]() |
Ketogenic Diets for Diabetes Mellitus and Obesity...
June 1, 2017 - Clinical , Featured By: Anna Chen, PharmD Candidate c/o 2020 – Every day the public faces an onslaught of a new fad diet that promises to prevent boredom and the feelings of restriction that regular diets are famous for. One example is the banana diet that promises to keep one satiated with the high volume and fiber content… |
![]() |
The function and efficacy of pimavanserin (Nuplazid®) ...
April 1, 2017 - Clinical , Featured By: Jonathan Mercado, PharmD Candidate c/o 2019 – In April 2016, the FDA approved the first drug specifically indicated for the symptoms of psychosis associated with Parkinson’s disease (PDP).1 Currently, clozapine and quetiapine are used off label to treat symptoms associated with Parkinson disease such as voices in patients’ heads, various hallucinations and delusions. In… |
![]() |
The Importance of Inhaler Education: A Comprehensive Re...
February 1, 2017 - Clinical , Featured By: Jack (Hongkai) Bao, PharmD Candidate c/o 2018 – Inhalers are one of the most prescribed therapies used to treat respiratory disorders in patients. Anticholinergics, β-agonists, and corticosteroids are all packaged into a miniature device that patients must use correctly every time to ensure delivery of their medication. To complicate matters, a myriad of inhaler… |
![]() |
Evaluating Pharmacy Curriculum Outcomes Assessment and ...
February 1, 2017 - Clinical , Featured By: Zachary Piracha, PharmD Candidate c/o 2017 – BACKGROUND The pharmacy profession is constantly fortified by an ever-evolving process by which students of pharmacy become practicing healthcare providers licensed in their respective states. The National Association of Boards of Pharmacy (NABP) carefully regulates the dissemination of tests as well as the shifting forms of administration… |
![]() |
Stevens-Johnson Syndrome: Physiological Progression and...
February 1, 2017 - Clinical , Featured By: Omar Rahman, PharmD Candidate c/o 2017 – Stevens-Johnson Syndrome is a unique skin disease that may be due to an infection, a response to medication, or other idiopathic causes. It is uncommon, as there are approximately only 20,000 cases worldwide annually. The etiology confirms that about half of the cases are in reaction to… |
![]() |
The Relationship Between Blueberry Supplementation and ...
February 1, 2017 - Clinical , Featured By: Amy Nguyen, PharmD Candidate c/o 2020 and Alex Chu, PharmD Candidate c/o 2019 – One of the most common problems with aging is the ability to maintain brain function. Dementia is a collective term describing conditions revolving the impairment of various brain functions. Patients with dementia often experience progressive behavioral and neurological changes that… |
![]() |
Brexpiprazole: A Novel Antipsychotic for Major Depressi...
October 1, 2016 - Clinical , Featured By: Nicollette Pacheco, Staff Editor [Graphics-focused] – Brexpiprazole (REXULTI®) is a novel atypical antipsychotic that was approved in July 2015 for the adjunctive treatment of Major Depressive Disorder (MDD) and as monotherapy in schizophrenia.1 Brexpiprazole is a serotonin-dopamine activity modulator with partial agonism at serotonergic 5HT1α and dopaminergic D2 receptors, as well as potent antagonism… |
![]() |
A Primer on HIV Pre-Exposure Prophylaxis (PrEP)...
March 1, 2016 - Clinical , Featured By: Svetlana Akbasheva, Section Editor (Clinical) – Despite the advances in the treatment of human immunodeficiency virus (HIV), the incidence of HIV transmission remains alarmingly high, with about 50,000 new cases arising every year in the United States alone.1 Recently, HIV management has turned its focus on prevention for high-risk, uninfected individuals in addition to… |
![]() |
Review of Thalidomide in Memory of Dr. Frances Oldham K...
February 1, 2016 - Clinical , Featured By: Kevin J. Choi, PharmD Candidate c/o 2016 – “Morning Sickness” – we have all heard of this term being associated with thalidomide, a drug particularly recognized for its antiemetic effect, but also for its notorious teratogenicity. However, it is worth re-familiarizing ourselves with the nature of the drug itself (and the clinical threats that… |
![]() |
The Reality behind a “Stone Heart”...
February 1, 2016 - Clinical , Featured By: Dimitrios Savva, PharmD c/o 2016 – Digoxin is a cardiac glycoside used in the treatment of atrial fibrillation (Afib) and heart failure. Digoxin inhibits sodium-potassium ATPase, leading to an increase in intracellular sodium which in turn inhibits sodium-dependent calcium transport out of the cytoplasm and ultimately results in an increase in intracellular calcium.1 The… |
![]() |
The Effect of Acetaminophen on Emotional Pain...
January 1, 2016 - Clinical , Featured By: Nicollette Pacheco, Staff Editor (Graphics-focused) – Acetaminophen, an analgesic and antipyretic, has been widely used to relieve minor aches and pains since the 1950s. The drug exhibits these effects by inhibiting the enzymes COX-1 and COX-2, and acts in both the central and peripheral nervous systems.1 While acetaminophen is currently indicated for the relief… |
![]() |
Appropriate Use of Antiepileptic Drugs for Prophylaxis ...
January 1, 2016 - Clinical , Featured By: Anthony Vecchione, PharmD Candidate c/o 2016 – Seizures are a well-described complication of acute brain injury and neurosurgery. Antiepileptic drugs (AEDs) are frequently utilized for seizure prophylaxis in neurocritical care patients, but this practice is controversial because of the possible adverse effects of these drugs (which can affect patient outcomes). Practitioners have prescribed AEDs… |
![]() |
Antipsychotic-Induced Obsessive-Compulsive Disorder...
December 1, 2015 - Clinical , Featured By: Cyril Collantes, PharmD Candidate c/o 2016 – Obsessive-Compulsive Disorder (OCD) is characterized by two predominant psychiatric components: obsession and compulsion. Obsession refers to the uncontrolled and recurrent thoughts, impulses, or images that can provoke significant anxiety, whereas compulsions are repetitive behaviors or rituals in response to the obsessive thought(s). OCD is clinically significant if… |
![]() |
FDA Approves Vorapaxar...
August 1, 2015 - Clinical , Featured By: Azia Tariq, Section Editor – Myocardial infarctions, more commonly known as heart attacks, are prevalent in the United States. Each year, approximately 720,000 Americans suffer a heart attack.1 The approval of vorapaxar by the Food and Drug Administration (FDA) presents an additional treatment option for patients at high risk for myocardial infarction and stroke.1,2… |
![]() |
A Link Between Genetics and the Treatment Prognosis of ...
July 1, 2015 - Clinical , Featured By: Jacqueline Meaney, PharmD [PGY-1 Resident at Gainesville VAMC in Florida] – Major depressive disorder (MDD) is a psychiatric disorder that is characterized by feelings of worthlessness, helplessness, and an inability to experience pleasure in activities that were enjoyable in the past.1 Major depressive disorder is one of the most prevalent mental disorders among adults… |